Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL445731 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL9100112 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL445732 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL6692257 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL23152455 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL56814 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL23152453 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL22323769 | 1.00 | CA2 (0.46) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL22323767 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL56813 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127108-B2 | Method for making polymer, and associated polymer, membrane and electrode | GENERAL ELECTRIC COMPANY (US) | 2015-09-08 | — | — | US | claimed |
| US-20120196140-A1 | METHOD FOR MAKING POLYMER, AND ASSOCIATED POLYMER, MEMBRANE AND ELECTRODE | GENERAL ELECTRIC COMPANY (US) | 2012-08-02 | — | — | US | claimed |
| EP-2474006-A2 | METHOD FOR MAKING POLYMER, COATING ELECTRODE, AND ASSOCIATED POLYMER AND ELECTRODE | General Electric Company (US) | 2012-07-11 | — | — | EP | claimed |
| US-20110049430-A1 | METHOD FOR MAKING POLYMER, COATING ELECTRODE, AND ASSOCIATED POLYMER AND ELECTRODE | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | US | claimed |
| WO-2011025678-A2 | METHOD FOR MAKING POLYMER, COATING ELECTRODE, AND ASSOCIATED POLYMER AND ELECTRODE | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | WO | claimed |
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| US-5608011-A | Crosslinkable polymer powder compositions | WACKER-CHEMIE GMBH (DE) | 1997-03-04 | — | — | US | claimed |
| EP-0702059-B1 | Crosslinked polymer-powder compositions | WACKER CHEMIE GMBH (DE) | 1996-12-18 | — | — | EP | claimed |
| US-20240173211-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | SHOFU INC. (JP) | 2024-05-30 | — | — | US | disclosed |
| EP-4321145-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | Shofu Inc. (JP) | 2024-02-14 | — | — | EP | disclosed |
| WO-2023048602-A1 | BUTADIENE NITRILE LATEX, LATEX COMPOSITION FOR DIP-MOLDING, AND DIP-MOLDED ARTICLE | PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING") (RU) | 2023-03-30 | — | — | WO | disclosed |
| WO-2023048601-A1 | BUTADIENE NITRILE LATEX, LATEX COMPOSITION FOR DIP-MOLDING, AND DIP-MOLDED ARTICLE | PUBLIC JOINT STOCK COMPANY "SIBUR HOLDING" (PJSC "SIBUR HOLDING") (RU) | 2023-03-30 | — | — | WO | disclosed |
| EP-3900086-B1 | ELECTRODE COMPOSITION FOR A CATHODE OF A CELL OF A LITHIUM-ION BATTERY, A CATHODE SLURRY COMPOSITION, A CATHODE AND THE BATTERY INCORPORATING IT | ARLANXEO DEUTSCHLAND GMBH (DE) | 2023-01-11 | — | — | EP | disclosed |
| US-11324669-B2 | Powder-liquid type dental resin-reinforced glass ionomer cement composition | SHOFU INC. (JP) | 2022-05-10 | — | — | US | disclosed |
| US-5608011-A | Crosslinkable polymer powder compositions | WACKER-CHEMIE GMBH (DE) | 1997-03-04 | — | — | US | disclosed |
| US-5508100-A | BINDING TWO OR MORE LAYERS OF CELLULAR PULP OR CELLULOSE FIBER TISSUES BY APPLYING BINDER CONSISTING OF PLASTIC DISPERSION BASED ON COPOLYMER OR TERPOLYMER, FILLERS, THICKENERS, DISPERSING AGENTS; AFFIXING AND DRYING | WACKER-CHEMIE GMBH (DE) | 1996-04-16 | — | — | US | disclosed |
| US-5314530-A | Vinyl chloride copolymer | WACKER CHEMIE GMBH (DE) | 1994-05-24 | — | — | US | disclosed |
| US-5278225-A | Comprising (meth)acrylates of alcohol monomer | WACKER-CHEMIE GMBH (DE) | 1994-01-11 | — | — | US | disclosed |
| US-5124401-A | Finely-divided vinyl chloride-ethylene copolymers stabilized by protection colloids | WACKER-CHEMIE GMBH (DE) | 1992-06-23 | — | — | US | disclosed |
| US-4528315-A | Process for the preparation of polymer dispersions and their application | WACKER-CHEMIE GMBH (DE) | 1985-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324669-B2 | Powder-liquid type dental resin-reinforced glass ionomer cement composition | WDR1, WDR91, ARID2 | CA2 609/4885SLC34A1 3222/4885KDM4E 650/4885 |
| US-20240173211-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT KIT | GRIK1, GRIN2B, GRIK2 | CA2 329/4885SLC34A1 4136/4885KDM4E 1288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.